| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARATANA THERAPEUTICS INC COM | 43,445 | 242,000 | 0.02% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 30,827 | 585,000 | 0.04% | ||
| 3 | PUMA BIOTECHNOLOGY | 11,000 | 862,000 | 0.07% | ||
| 4 | DBV TECHNOLOGIES | 25,000 | 908,000 | 0.07% | ||
| 5 | MIRNA THERAPEUTICS INC | 150,000 | 938,000 | 0.07% | ||
| 6 | SOPHIRIS BIO INC | 628,563 | 1,138,000 | 0.09% | ||
| 7 | BLUEBIRD BIO INCORPORATED | 20,000 | 1,284,000 | 0.10% | ||
| 8 | INFINITY PHARMACEUTICALS INC COM | 215,000 | 1,688,000 | 0.13% | ||
| 9 | CERULEAN PHARMA INC | 625,000 | 1,750,000 | 0.13% | ||
| 10 | ANTHERA PHARMACEUTICALS I | 380,000 | 1,763,000 | 0.13% | ||
| 11 | TETRAPHASE PHARMACEUTICALS I COM | 200,000 | 2,006,000 | 0.15% | ||
| 12 | SAREPTA THERAPEUTICS INC | 53,300 | 2,056,000 | 0.16% | Call | |
| 13 | Nabriva Therapeutics AG | 235,000 | 2,244,000 | 0.17% | ||
| 14 | GLOBAL BLOOD THERAPEUTICS IN COM | 70,500 | 2,279,000 | 0.17% | ||
| 15 | INTERCEPT PHARMACEUTICAL | 15,500 | 2,315,000 | 0.18% | ||
| 16 | GENOCEA BIOSCIENCES INC | 480,000 | 2,530,000 | 0.19% | ||
| 17 | ASSEMBLY BIOSCIENCES INC | 371,000 | 2,786,000 | 0.21% | ||
| 18 | Orexigen Therapeutics, Inc. | 1,650,000 | 2,838,000 | 0.22% | ||
| 19 | DIMENSION THERAPEUTICS INC COM | 271,370 | 3,061,000 | 0.23% | ||
| 20 | Egalet Corp | 300,000 | 3,306,000 | 0.25% | ||
| 21 | RIGEL PHARMACEUTICAL INC | 1,100,000 | 3,333,000 | 0.25% | ||
| 22 | DYNAVAX TECHNOLOGIES CORP | 150,000 | 3,624,000 | 0.27% | ||
| 23 | Nivalis Therapeutics Inc | 489,000 | 3,785,000 | 0.29% | ||
| 24 | SCYNEXIS INC | 635,000 | 3,943,000 | 0.30% | ||
| 25 | Life Technologies Corp | 415,196 | 4,081,000 | 0.31% | ||
| 26 | SAREPTA THERAPEUTICS INC | 107,500 | 4,147,000 | 0.31% | ||
| 27 | CIDARA THERAPEUTICS INC | 250,000 | 4,290,000 | 0.33% | ||
| 28 | PERRIGO CO PLC | 30,000 | 4,341,000 | 0.33% | ||
| 29 | CLOVIS ONCOLOGY INC | 125,000 | 4,375,000 | 0.33% | ||
| 30 | DYAX CORP COM CVR | 124,000 | 4,665,000 | 0.35% | ||
| 31 | AIMMUNE THERAPEUTICS INC COM | 259,646 | 4,790,000 | 0.36% | ||
| 32 | NOVOCURE LTD | 214,316 | 4,792,000 | 0.36% | ||
| 33 | ENDOCHOICE HLDGS INC | 590,000 | 4,927,000 | 0.37% | ||
| 34 | KITE PHARMA INCORPORATED | 80,000 | 4,930,000 | 0.37% | ||
| 35 | Ascendis Pharma | 270,000 | 4,946,000 | 0.37% | ||
| 36 | INVITAE CORP | 622,900 | 5,114,000 | 0.39% | ||
| 37 | ALLERGAN PLC | 5,000 | 5,136,000 | 0.39% | ||
| 38 | Compugen Ltd | 805,000 | 5,144,000 | 0.39% | ||
| 39 | ABBVIE INC | 87,500 | 5,184,000 | 0.39% | ||
| 40 | Otonomy Inc | 197,500 | 5,481,000 | 0.42% | ||
| 41 | AMICUS THERAPEUTICS INC | 566,500 | 5,495,000 | 0.42% | ||
| 42 | FIVE PRIME THERAPEUTICS INC | 135,000 | 5,603,000 | 0.42% | ||
| 43 | CHINA CORD BLOOD CORP SHS | 880,000 | 5,606,000 | 0.42% | ||
| 44 | FIBROGEN INC COM | 190,000 | 5,789,000 | 0.44% | ||
| 45 | COOPER COS INC | 44,000 | 5,905,000 | 0.45% | ||
| 46 | EPIZYME INC COM | 370,000 | 5,927,000 | 0.45% | ||
| 47 | REGENERON PHARMACEUTICALS | 11,000 | 5,972,000 | 0.45% | ||
| 48 | XENOPORT INC | 1,100,000 | 6,039,000 | 0.46% | ||
| 49 | ATHENA HEALTH INC. | 39,500 | 6,358,000 | 0.48% | ||
| 50 | ENVISION HEALTHCARE HLDGS INC | 245,000 | 6,363,000 | 0.48% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-002886, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
